Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Analgesic & Pain Relievers
1.2.3 Dermatological Products
1.2.4 Cough, Cold, and Flu Products
1.2.5 Vitamin Supplements
1.2.6 Mineral Supplements
1.2.7 Ophthalmic Products
1.3 Market by Application
1.3.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacy
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Perspective (2016-2027)
2.2 Over the Counter (OTC) Drugs & Dietary Supplements Growth Trends by Regions
2.2.1 Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Over the Counter (OTC) Drugs & Dietary Supplements Historic Market Share by Regions (2016-2021)
2.2.3 Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Regions (2022-2027)
2.3 Over the Counter (OTC) Drugs & Dietary Supplements Industry Dynamic
2.3.1 Over the Counter (OTC) Drugs & Dietary Supplements Market Trends
2.3.2 Over the Counter (OTC) Drugs & Dietary Supplements Market Drivers
2.3.3 Over the Counter (OTC) Drugs & Dietary Supplements Market Challenges
2.3.4 Over the Counter (OTC) Drugs & Dietary Supplements Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Over the Counter (OTC) Drugs & Dietary Supplements Players by Revenue
3.1.1 Global Top Over the Counter (OTC) Drugs & Dietary Supplements Players by Revenue (2016-2021)
3.1.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Players (2016-2021)
3.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Over the Counter (OTC) Drugs & Dietary Supplements Revenue
3.4 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Concentration Ratio
3.4.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Over the Counter (OTC) Drugs & Dietary Supplements Revenue in 2020
3.5 Over the Counter (OTC) Drugs & Dietary Supplements Key Players Head office and Area Served
3.6 Key Players Over the Counter (OTC) Drugs & Dietary Supplements Product Solution and Service
3.7 Date of Enter into Over the Counter (OTC) Drugs & Dietary Supplements Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Over the Counter (OTC) Drugs & Dietary Supplements Breakdown Data by Type
4.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Historic Market Size by Type (2016-2021)
4.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Type (2022-2027)

5 Over the Counter (OTC) Drugs & Dietary Supplements Breakdown Data by Application
5.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Historic Market Size by Application (2016-2021)
5.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2016-2027)
6.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type
6.2.1 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2016-2021)
6.2.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2022-2027)
6.2.3 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2016-2027)
6.3 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application
6.3.1 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2016-2021)
6.3.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2022-2027)
6.3.3 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2016-2027)
6.4 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country
6.4.1 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2016-2021)
6.4.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2016-2027)
7.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type
7.2.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2016-2021)
7.2.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2022-2027)
7.2.3 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2016-2027)
7.3 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application
7.3.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2016-2021)
7.3.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2022-2027)
7.3.3 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2016-2027)
7.4 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country
7.4.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2016-2021)
7.4.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2016-2027)
8.2 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type
8.2.1 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2016-2027)
8.3 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application
8.3.1 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2016-2027)
8.4 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region
8.4.1 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2016-2027)
9.2 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type
9.2.1 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2016-2021)
9.2.2 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2022-2027)
9.2.3 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2016-2027)
9.3 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application
9.3.1 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2016-2021)
9.3.2 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2022-2027)
9.3.3 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2016-2027)
9.4 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country
9.4.1 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2016-2021)
9.4.2 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2016-2027)
10.2 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type
10.2.1 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2016-2027)
10.3 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application
10.3.1 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2016-2027)
10.4 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country
10.4.1 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Company Details
11.1.2 Pfizer Inc. Business Overview
11.1.3 Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.1.4 Pfizer Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021)
11.1.5 Pfizer Inc. Recent Development
11.2 Novartis International AG
11.2.1 Novartis International AG Company Details
11.2.2 Novartis International AG Business Overview
11.2.3 Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.2.4 Novartis International AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021)
11.2.5 Novartis International AG Recent Development
11.3 Roche Holding AG
11.3.1 Roche Holding AG Company Details
11.3.2 Roche Holding AG Business Overview
11.3.3 Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.3.4 Roche Holding AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021)
11.3.5 Roche Holding AG Recent Development
11.4 Merck & Co., Inc.
11.4.1 Merck & Co., Inc. Company Details
11.4.2 Merck & Co., Inc. Business Overview
11.4.3 Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.4.4 Merck & Co., Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021)
11.4.5 Merck & Co., Inc. Recent Development
11.5 Sanofi S.A
11.5.1 Sanofi S.A Company Details
11.5.2 Sanofi S.A Business Overview
11.5.3 Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.5.4 Sanofi S.A Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021)
11.5.5 Sanofi S.A Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.6.4 Johnson & Johnson Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021)
11.6.5 Johnson & Johnson Recent Development
11.7 Gilead Sciences
11.7.1 Gilead Sciences Company Details
11.7.2 Gilead Sciences Business Overview
11.7.3 Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.7.4 Gilead Sciences Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021)
11.7.5 Gilead Sciences Recent Development
11.8 GlaxoSmithKline plc.
11.8.1 GlaxoSmithKline plc. Company Details
11.8.2 GlaxoSmithKline plc. Business Overview
11.8.3 GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.8.4 GlaxoSmithKline plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021)
11.8.5 GlaxoSmithKline plc. Recent Development
11.9 Bayer Healthcare AG
11.9.1 Bayer Healthcare AG Company Details
11.9.2 Bayer Healthcare AG Business Overview
11.9.3 Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.9.4 Bayer Healthcare AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021)
11.9.5 Bayer Healthcare AG Recent Development
11.10 AstraZeneca plc.
11.10.1 AstraZeneca plc. Company Details
11.10.2 AstraZeneca plc. Business Overview
11.10.3 AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.10.4 AstraZeneca plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021)
11.10.5 AstraZeneca plc. Recent Development
11.11 Alacer Corp.
11.11.1 Alacer Corp. Company Details
11.11.2 Alacer Corp. Business Overview
11.11.3 Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.11.4 Alacer Corp. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021)
11.11.5 Alacer Corp. Recent Development
11.12 Alcon Inc.
11.12.1 Alcon Inc. Company Details
11.12.2 Alcon Inc. Business Overview
11.12.3 Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.12.4 Alcon Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021)
11.12.5 Alcon Inc. Recent Development
11.13 Alfresa Pharma Corporation
11.13.1 Alfresa Pharma Corporation Company Details
11.13.2 Alfresa Pharma Corporation Business Overview
11.13.3 Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.13.4 Alfresa Pharma Corporation Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021)
11.13.5 Alfresa Pharma Corporation Recent Development
11.14 Alkalon A/S
11.14.1 Alkalon A/S Company Details
11.14.2 Alkalon A/S Business Overview
11.14.3 Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.14.4 Alkalon A/S Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021)
11.14.5 Alkalon A/S Recent Development
11.15 Alliance Healthcare
11.15.1 Alliance Healthcare Company Details
11.15.2 Alliance Healthcare Business Overview
11.15.3 Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.15.4 Alliance Healthcare Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021)
11.15.5 Alliance Healthcare Recent Development
11.16 Allergan, Plc.
11.16.1 Allergan, Plc. Company Details
11.16.2 Allergan, Plc. Business Overview
11.16.3 Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.16.4 Allergan, Plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021)
11.16.5 Allergan, Plc. Recent Development
11.17 Reckitt Benckiser Plc.
11.17.1 Reckitt Benckiser Plc. Company Details
11.17.2 Reckitt Benckiser Plc. Business Overview
11.17.3 Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.17.4 Reckitt Benckiser Plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021)
11.17.5 Reckitt Benckiser Plc. Recent Development
11.18 Bausch & Lomb
11.18.1 Bausch & Lomb Company Details
11.18.2 Bausch & Lomb Business Overview
11.18.3 Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.18.4 Bausch & Lomb Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021)
11.18.5 Bausch & Lomb Recent Development
11.18 AbbVie Inc.
.1 AbbVie Inc. Company Details
.2 AbbVie Inc. Business Overview
.3 AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
.4 AbbVie Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021)
.5 AbbVie Inc. Recent Development
11.20 The Colgate-Palmolive Company
11.20.1 The Colgate-Palmolive Company Company Details
11.20.2 The Colgate-Palmolive Company Business Overview
11.20.3 The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.20.4 The Colgate-Palmolive Company Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021)
11.20.5 The Colgate-Palmolive Company Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Analgesic & Pain Relievers
Table 3. Key Players of Dermatological Products
Table 4. Key Players of Cough, Cold, and Flu Products
Table 5. Key Players of Vitamin Supplements
Table 6. Key Players of Mineral Supplements
Table 7. Key Players of Ophthalmic Products
Table 8. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Regions (2016-2021)
Table 12. Global Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Regions (2022-2027)
Table 14. Over the Counter (OTC) Drugs & Dietary Supplements Market Trends
Table 15. Over the Counter (OTC) Drugs & Dietary Supplements Market Drivers
Table 16. Over the Counter (OTC) Drugs & Dietary Supplements Market Challenges
Table 17. Over the Counter (OTC) Drugs & Dietary Supplements Market Restraints
Table 18. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Players (2016-2021)
Table 20. Global Top Over the Counter (OTC) Drugs & Dietary Supplements Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Over the Counter (OTC) Drugs & Dietary Supplements as of 2020)
Table 21. Ranking of Global Top Over the Counter (OTC) Drugs & Dietary Supplements Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Over the Counter (OTC) Drugs & Dietary Supplements Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Over the Counter (OTC) Drugs & Dietary Supplements Product Solution and Service
Table 25. Date of Enter into Over the Counter (OTC) Drugs & Dietary Supplements Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Type (2016-2021)
Table 29. Global Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Application (2016-2021)
Table 33. Global Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2022-2027) & (US$ Million)
Table 65. Pfizer Inc. Company Details
Table 66. Pfizer Inc. Business Overview
Table 67. Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 68. Pfizer Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021) & (US$ Million)
Table 69. Pfizer Inc. Recent Development
Table 70. Novartis International AG Company Details
Table 71. Novartis International AG Business Overview
Table 72. Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 73. Novartis International AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021) & (US$ Million)
Table 74. Novartis International AG Recent Development
Table 75. Roche Holding AG Company Details
Table 76. Roche Holding AG Business Overview
Table 77. Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 78. Roche Holding AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021) & (US$ Million)
Table 79. Roche Holding AG Recent Development
Table 80. Merck & Co., Inc. Company Details
Table 81. Merck & Co., Inc. Business Overview
Table 82. Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 83. Merck & Co., Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021) & (US$ Million)
Table 84. Merck & Co., Inc. Recent Development
Table 85. Sanofi S.A Company Details
Table 86. Sanofi S.A Business Overview
Table 87. Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 88. Sanofi S.A Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021) & (US$ Million)
Table 89. Sanofi S.A Recent Development
Table 90. Johnson & Johnson Company Details
Table 91. Johnson & Johnson Business Overview
Table 92. Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 93. Johnson & Johnson Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021) & (US$ Million)
Table 94. Johnson & Johnson Recent Development
Table 95. Gilead Sciences Company Details
Table 96. Gilead Sciences Business Overview
Table 97. Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 98. Gilead Sciences Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021) & (US$ Million)
Table 99. Gilead Sciences Recent Development
Table 100. GlaxoSmithKline plc. Company Details
Table 101. GlaxoSmithKline plc. Business Overview
Table 102. GlaxoSmithKline plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021) & (US$ Million)
Table 103. GlaxoSmithKline plc. Recent Development
Table 104. Bayer Healthcare AG Company Details
Table 105. Bayer Healthcare AG Business Overview
Table 106. Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 107. Bayer Healthcare AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021) & (US$ Million)
Table 108. Bayer Healthcare AG Recent Development
Table 109. AstraZeneca plc. Company Details
Table 110. AstraZeneca plc. Business Overview
Table 111. AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 112. AstraZeneca plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021) & (US$ Million)
Table 113. AstraZeneca plc. Recent Development
Table 114. Alacer Corp. Company Details
Table 115. Alacer Corp. Business Overview
Table 116. Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 117. Alacer Corp. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021) & (US$ Million)
Table 118. Alacer Corp. Recent Development
Table 119. Alcon Inc. Company Details
Table 120. Alcon Inc. Business Overview
Table 121. Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 122. Alcon Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021) & (US$ Million)
Table 123. Alcon Inc. Recent Development
Table 124. Alfresa Pharma Corporation Company Details
Table 125. Alfresa Pharma Corporation Business Overview
Table 126. Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 127. Alfresa Pharma Corporation Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021) & (US$ Million)
Table 128. Alfresa Pharma Corporation Recent Development
Table 129. Alkalon A/S Company Details
Table 130. Alkalon A/S Business Overview
Table 131. Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 132. Alkalon A/S Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021) & (US$ Million)
Table 133. Alkalon A/S Recent Development
Table 134. Alliance Healthcare Company Details
Table 135. Alliance Healthcare Business Overview
Table 136. Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 137. Alliance Healthcare Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021) & (US$ Million)
Table 138. Alliance Healthcare Recent Development
Table 139. Allergan, Plc. Company Details
Table 140. Allergan, Plc. Business Overview
Table 141. Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 142. Allergan, Plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021) & (US$ Million)
Table 143. Allergan, Plc. Recent Development
Table 144. Reckitt Benckiser Plc. Company Details
Table 145. Reckitt Benckiser Plc. Business Overview
Table 146. Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 147. Reckitt Benckiser Plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021) & (US$ Million)
Table 148. Reckitt Benckiser Plc. Recent Development
Table 149. Bausch & Lomb Company Details
Table 150. Bausch & Lomb Business Overview
Table 151. Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 152. Bausch & Lomb Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021) & (US$ Million)
Table 153. Bausch & Lomb Recent Development
Table 154. AbbVie Inc. Company Details
Table 155. AbbVie Inc. Business Overview
Table 156. AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 157. AbbVie Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021) & (US$ Million)
Table 158. AbbVie Inc. Recent Development
Table 159. The Colgate-Palmolive Company Company Details
Table 160. The Colgate-Palmolive Company Business Overview
Table 161. The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 162. The Colgate-Palmolive Company Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021) & (US$ Million)
Table 163. The Colgate-Palmolive Company Recent Development
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type: 2020 VS 2027
Figure 2. Analgesic & Pain Relievers Features
Figure 3. Dermatological Products Features
Figure 4. Cough, Cold, and Flu Products Features
Figure 5. Vitamin Supplements Features
Figure 6. Mineral Supplements Features
Figure 7. Ophthalmic Products Features
Figure 8. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application: 2020 VS 2027
Figure 9. Hospital Pharmacies Case Studies
Figure 10. Retail Pharmacies Case Studies
Figure 11. Online Pharmacy Case Studies
Figure 12. Others Case Studies
Figure 13. Over the Counter (OTC) Drugs & Dietary Supplements Report Years Considered
Figure 14. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Regions: 2020 VS 2027
Figure 17. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Regions (2022-2027)
Figure 18. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Players in 2020
Figure 19. Global Top Over the Counter (OTC) Drugs & Dietary Supplements Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Over the Counter (OTC) Drugs & Dietary Supplements as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Over the Counter (OTC) Drugs & Dietary Supplements Revenue in 2020
Figure 21. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Type (2016-2021)
Figure 22. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Type (2022-2027)
Figure 23. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type (2016-2027)
Figure 25. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application (2016-2027)
Figure 26. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Country (2016-2027)
Figure 27. United States Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type (2016-2027)
Figure 31. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application (2016-2027)
Figure 32. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Country (2016-2027)
Figure 33. Germany Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Region (2016-2027)
Figure 43. China Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type (2016-2027)
Figure 51. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application (2016-2027)
Figure 52. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Country (2016-2027)
Figure 53. Mexico Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Country (2016-2027)
Figure 59. Turkey Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Pfizer Inc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021)
Figure 63. Novartis International AG Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021)
Figure 64. Roche Holding AG Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021)
Figure 65. Merck & Co., Inc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021)
Figure 66. Sanofi S.A Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021)
Figure 67. Johnson & Johnson Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021)
Figure 68. Gilead Sciences Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021)
Figure 69. GlaxoSmithKline plc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021)
Figure 70. Bayer Healthcare AG Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021)
Figure 71. AstraZeneca plc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021)
Figure 72. Alacer Corp. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021)
Figure 73. Alcon Inc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021)
Figure 74. Alfresa Pharma Corporation Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021)
Figure 75. Alkalon A/S Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021)
Figure 76. Alliance Healthcare Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021)
Figure 77. Allergan, Plc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021)
Figure 78. Reckitt Benckiser Plc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021)
Figure 79. Bausch & Lomb Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021)
Figure 80. AbbVie Inc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021)
Figure 81. The Colgate-Palmolive Company Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2016-2021)
Figure 82. Bottom-up and Top-down Approaches for This Report
Figure 83. Data Triangulation
Figure 84. Key Executives Interviewed